Norbert G. Riedel, Director at Eton Pharmaceuticals, Inc. (ETON), bought 5,000 shares at $6.00 ($30K) on 2018-11-15, disclosed to the SEC on 2018-11-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| JAZZ | SELL | 2022-08-09 | $1.6M | — | Filing → |
| APTX | BUY | 2021-12-08 | $223K | — | Filing → |
| JAZZ | SELL | 2021-08-10 | $386K | — | Filing → |